FDA Investigator Mra Munizn
Mra Munizn has inspections in 11 countries as of 11 Oct 2023. Mra Munizn has collaborated with a combinined 3659 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
37
Last Inspection Date:
11 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Ireland,
Belgium,
Italy,
United Kingdom of Great Britain and Northern Ireland,
Spain,
Denmark,
Germany,
Latvia,
Japan,
Czechia,
Netherlands
Co-Investigator(s):
Ademola O Daramola,
Alicia M Mozzachio,
Anastasia M Shields,
Angela E Glenn,
Anh M Lac,
Anissa M Cheung,
Anita Narula, PhD,
Anita R Michael,
Ann L Demarco,
Antonina Aydanian,
Ariel Cruz Figueroa,
Azza Talaat,
Bill Tacket, Jr,
Bo Chi, PhD,
Bonita S Chester,
Brandon C Heitmeier,
Brenda W Uratani, PhD,
Brian D Nicholson,
Brittany D Terhar,
Bruce H Mccullough,
Burnell M Henry,
Carl A Huffman, III,
Carl Lee,
Caryn M Everly,
Caryn M Mcnab,
Catherine J Laufmann,
CDR Rochelle B Young, RPh, MSA,
Christina A Miller,
Christina V Santos,
Christopher D Leach,
Christopher Downey, PhD,
Christopher R Czajka,
Cynthia J Lee, MS,
Cynthia Jim, CSO,
Daphne Santiago, PhD,
Debra I Love,
Demitria J Xiradakis,
Dennis Cantellops Paite,
Devaughn Edwards,
Dhaval H Patel,
Diane L Raccasi,
Doan T Nguyen, PharmD,
Don H Bark, PhD,
Donald C Obenhuber, PhD,
Douglas A Campbell,
Dr. Ralph M Bernstein, PhD,
Edwin Melendez,
Eliezar Ramos,
Eric L Dong, BS,
Eric M Mueller, PharmD,
Erika V Butler,
Farhana Khan,
Felix Maldonado,
Gerald B Seaborn, Jr,
Geraldine D Sanders,
Geraldine Sanders,
Helen B Ricalde,
Helen Verdel,
Ivis Lnegron Torres,
Jacqueline Mdiaz Albertini,
James C Maclaughlin,
James D Bridges,
James I Giefer,
Joan M Cantellops Figueroa,
John D White,
Jose Acruz Gonzalez,
Jose E Melendez, DDC,
Jose R Hernandez,
Joseph T Dougherty,
Julie D Bringger,
Justin A Boyd,
Kalavati Suvarna, PhD,
Katherine Szestypalow,
Kathleen R Jones, PhD,
Kent C Faul,
Kevin A Gonzalez,
Kevin P Foley,
Kham Phommachanh,
Kumar G Janoria,
Kurt A Brorson, PhD,
Laura Fontan, MS,
Lewis K Antwi,
Linda F Murphy,
Lindsey M Schwierjohann,
Lucas B Leake,
Luella J Rossi,
Lynda L Perry, PhD,
Madushini Sharmasena, PhD,
Margaret M Annes,
Margarita Santiago,
Maria Joselopez Barragan, PhD,
Marie F Morin,
Marion Michaelis,
Mariza M Jafary,
Mark Brunswick, PhD,
Marvin D Jones,
Mary E Farbman, PhD,
Mary E Storch,
Massoud Motamed,
Matthew B Casale,
Maya M Davis,
Megan A Haggerty,
Meisha R Sampson,
Meisha Waters,
Melissa D Ray,
Michael A Taylor,
Michael E Maselli,
Michael R Goga,
Michael Shanks, MS,
Michele L Forster, PhD,
Michele L Obert,
Michele Perry Williams,
Michelle Y Clark Stuart,
Miguel A Martinez,
Mihaly S Ligmond,
Milos Dokmanovic, PhD,
Milva E Melendez,
Monica Commerford, PhD,
Mra Davism,
Nadeem I Chaudhry,
Nancy G Schmidt,
Nancy L Rolli,
Nicholas L Paulin,
Noreen Muniz,
Omotunde O Osunsanmi,
Parul M Patel,
Patricia D Stahnke,
Patsy J Domingo,
Paul Mouris,
Paula A Trost,
Peggy M Speight,
Philip F Istafanos, DMV, MS,
Prabhu P Raju,
Qing Joanna Zhou, PhD,
Rafael E Arroyo,
Ralph A Erickson,
Randa Melhem, PhD,
Rebecca E Dombrowski,
Regina T Brown,
Reyes Candau Chacon, PhD,
Richard Ledwidge (nmi), PhD,
Richard W Berning,
Riley C Myers, PhD,
Robert J Martin,
Robert M Barbosa,
Robert W Jennings,
Rose M Ashley,
Russell K Riley,
Saleem A Akhtar,
Samantha J Bradley,
Samina S Khan,
Sandra A Hughes,
Sangeeta M Khurana, PhD,
Satheesh Thomas,
Scott R Nichols, PhD,
Scott T Ballard,
Sean Fitzsimmons,
Sean R Marcsisin,
Sharon K Thoma, PharmD,
Shirley J Berryman,
Simone E Pitts,
Sonia R Peterson,
Stephen J Koniers,
Susan M Jackson,
Susan W Ting,
Susanna E Ford, Analyst,
Susant Hadman,
Tajah L Blackburn,
Tamil Arasu, PhD,
Temar Q Williams,
Tenzin Jangchup,
Terri L Dodds,
Thomas E Friel,
Thomas J Arista,
Thuy T Nguyen, LCDR,
Timothy T Kapsala,
Tonia F Bernard,
Torrance J Slayton,
Uduak M Inokon,
Unnee Ranjan,
Veronica Fuentes, MS,
Vioela J Caze,
Virgilio F Pacio, CSO,
Viviana Matta,
Walter N Lange,
Wayne E Seifert,
William J Leonard,
Yanming An, PhD,
Yumi J Hiramine,
Yvins Dezan,
Zachary A Bogorad,
Zerita White,
Zhihao Qiu (Peter), PhD,
Zhong Li, PhD,
Zhongren Wu,
Ziyang Su, PhD
Mra Munizn's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| December, 2022 | FDA 483 | Bushu Pharmaceuticals, Ltd. - Form 483, 2022-12-02 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more